E-cigarette or drug-delivery device? Regulating novel nicotine products

New England Journal of Medicine

Volumn 365, Issue 3, 2011, Pages 193-195

  Cobb, Nathan K ^a,b,c   Abrams, David B ^a,c  

^a American Legacy Foundation   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; PROPYLENE GLYCOL;

ACT; CIGARETTE SMOKING; DEVICE APPROVAL; DEVICE SAFETY; DRUG ABUSE; DRUG DELIVERY SYSTEM; E CIGARETTE; GOVERNMENT REGULATION; LETHAL DOSE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; SHORT SURVEY; SMOKING CESSATION; STANDARD; TOBACCO DEPENDENCE; TOBACCO INDUSTRY; TOXICITY;

EID: 79960612944     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1105249     Document Type: Short Survey

References (5)

1. Deyton LR, Woodcock J. Regulation of e-cigarettes and other tobacco products. Silver Spring, MD: Food and Drug Administration, April 25, 2011. (http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm252360.htm.)
2. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the "e-cigarette." Am J Public Health 2010;100:2340-2.
3. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2010;12:905-12.
4. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control 2010;19:87-8.
5. Rose JE, Turner JE, Murugesan T, Behm FM, Laugesen M. Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics. Exp Clin Psychopharmacol 2010;18:385-94. [Erratum, Exp Clin Psychopharmacol 2011;19:iii.]